Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Lingbao Ai

1PUBLICATIONS
19CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Apr 21, 2026
CerS2 is a druggable target in triple-negative breast cancer.

Pageof 1

Frequent Collaborators

1 joint publications

Hissah Alatawi

1 joint publications

Haritha H Nair

1 joint publications

Iqbal Mahmud

1 joint publications

Abhishek Gour

1 joint publications

Amandeep Singh

1 joint publications

Doohyun Baek

1 joint publications

Bowen Yan

1 joint publications

Chandra K Maharjan

1 joint publications

Weizhou Zhang

1 joint publications

Brian K Law

Frequent Collaborators

1 joint publications

Hissah Alatawi

1 joint publications

Haritha H Nair

1 joint publications

Iqbal Mahmud

1 joint publications

Abhishek Gour

Top Related Videos

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on : Apr 26, 2024

4.2K
See more related videos

Top Related Videos

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on : Apr 26, 2024

4.2K
See more related videos